ad
This Article
Right arrow Full Version
Services
Right arrow E-mail this link to a friend
Right arrow Related text in Red Book
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Section 1
Section 2
Section 3
Section 4
Section 5
Appendices

The following text is from an archived Red Book® edition and may not reflect current recommendations or information. To view the current edition, click here.

The first 20% of the full text of this section appears below.

Section 4. Antimicrobial Agents and Related Therapy

MEDWATCH—THE FDA SAFETY INFORMATION AND ADVERSE EVENT REPORTING PROGRAM

MedWatch, the Food and Drug Administration (FDA) Safety Information and Adverse Event Reporting Program, is an outreach program for the health care system, including physicians, nurses, pharmacists, and patients, to enhance the effectiveness of the FDA’s risk management activities for all regulated clinical medical products. These products include . . . [Go to Full Text]


Related text in Red Book:

Reporting of Adverse Events

Red Book 2006: 41-50. [Extract] [Full Version]  

Improving Blood Safety

Red Book 2006: 121-123. [Extract] [Full Version]  

Chlamydia trachomatis

Red Book 2006: 252-257. [Extract] [Full Version]  

Pertussis (Whooping Cough)

Red Book 2006: 498-520. [Extract] [Full Version]